ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
Home » Archive by Category

Xconomy

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place

April 6, 2015 – 12:00 am

I’ve reached the stage of my career where I’ve been invited to give “career retrospective talks” to grad students and post-docs at academic institutions. It’s been an interesting and enjoyable…

[[Click headline to continue reading.]]

Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place

April 6, 2015 – 12:00 am

I’ve reached the stage of my career where I’ve been invited to give “career retrospective talks” to grad students and post-docs at academic institutions. It’s been an interesting and enjoyable…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More

April 2, 2015 – 1:19 pm

Xconomy national biotech editor Alex Lash is out wandering in the desert this week, so I’m stepping in as drover, and as biotech herds go, the one I’m rounding up today covers a lot of…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More

April 2, 2015 – 1:19 pm

Xconomy national biotech editor Alex Lash is out wandering in the desert this week, so I’m stepping in as drover, and as biotech herds go, the one I’m rounding up today covers a lot of…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Auspex, Hyperion, NuVasive, & More

April 2, 2015 – 1:19 pm

Xconomy national biotech editor Alex Lash is out wandering in the desert this week, so I’m stepping in as drover, and as biotech herds go, the one I’m rounding up today covers a lot of…

[[Click headline to continue reading.]]